Leukocare AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Leukocare AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10571
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying processes, development of individual SPS formulations meeting individual needs of target proteins, and development of customized lyophilization protocols. It also provides coupling of biological compounds to functionalize surfaces, development of vaccine formulation, and establishment of biological readouts. Leukocare offers its services in the areas of biophysics, physiology, biochemistry, pharmacology, immunology, pharmaceutical technology, chemistry and medical engineering, among others. The company provides its services across Germany. Leukocare is headquartered in Munich, Germany.

Leukocare AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Leukocare AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Leukocare and Xellia Pharma Enter into Partnership Agreement 12
Rentschler Biotech Enters into Agreement with Leukocare 13
Leukocare Enters into Agreement with Technical University of Munich 14
Licensing Agreements 15
PaxVax Enters into Licensing Agreement with Leukocare 15
Leukocare AG – Key Competitors 16
Leukocare AG – Key Employees 17
Leukocare AG – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Mar 09, 2018: Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation 19
Sep 14, 2017: LEUKOCARE Continues to Expand and Invests in Research and Development 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Leukocare AG, Pharmaceuticals & Healthcare, Key Facts 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Leukocare and Xellia Pharma Enter into Partnership Agreement 12
Rentschler Biotech Enters into Agreement with Leukocare 13
Leukocare Enters into Agreement with Technical University of Munich 14
PaxVax Enters into Licensing Agreement with Leukocare 15
Leukocare AG, Key Competitors 16
Leukocare AG, Key Employees 17

List of Figures
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Leukocare AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • GOBARTO S.A.:企業の戦略・SWOT・財務情報
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SEACOR Holdings Inc.:企業の戦略・SWOT・財務分析
    SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Siem Offshore Inc (SIOFF):企業の財務・戦略的SWOT分析
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. It offers shipbuilding, ordering and delivery of new vessels, acquisition of modern second-hand …
  • Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析
    Summary Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company that discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of …
  • Humana Inc (HUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • NuStar Energy LP (NS):石油・ガス:M&Aディール及び事業提携情報
    Summary NuStar Energy LP (NuStar Energy) is a midstream oil and gas company. It carries out the transportation, terminalling, storage and marketing of petroleum products, and anhydrous ammonia. The company owns and operates pipelines, terminal and storage facilities that store and distribute crude o …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Sultan Center Food Products Co. KSC (SULTAN):企業の財務・戦略的SWOT分析
    Sultan Center Food Products Co. KSC (SULTAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Mari Petroleum Co Ltd (MARI):企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • REC Silicon ASA (REC):電力:M&Aディール及び事業提携情報
    Summary REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, is a producer of advanced silicon materials, and delivers high-purity polysilicon and silicon gas. Its products find application in the solar and electronics industries in the production of solar panels, flat panel dis …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • Volpara Health Technologies Ltd (VHT):医療機器:M&Aディール及び事業提携情報
    Summary Volpara Health Technologies Ltd (Volpara Health) is a medical equipment company that develops and manufactures breast imaging analytics and analysis products that improve clinical decision-making and early detection of breast cancer. The company offers clinically-validated software products …
  • Tongaat Hulett Ltd (TON):企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Beckman Coulter Inc:企業の戦略的SWOT分析
    Beckman Coulter Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Capstone Turbine Corporation (CPST):電力:M&Aディール及び事業提携情報
    Summary Capstone Turbine Corporation (CPST) is an energy company. It develops, manufactures, markets, and services microturbine technology solutions and power generation systems. The company integrates air bearing technology, advanced combustion technology, and power electronics to form efficient an …
  • Daiwa Can Co., Ltd.:企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆